Benitec Biopharma Inc.
BNTC
$14.10
$0.322.32%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.64% | 32.32% | 15.39% | 33.37% | 259.65% |
| Total Receivables | 1,000.00% | 50.00% | -50.00% | -98.25% | 332.08% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 73.96% | -1.37% | -14.08% | -17.44% | 228.66% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 79.37% | 1.61% | -3.13% | 1.59% | 384.62% |
| Total Current Assets | -5.28% | 32.14% | 15.19% | 32.24% | 259.70% |
|
|
|||||
| Total Current Assets | -5.28% | 32.14% | 15.19% | 32.24% | 259.70% |
| Net Property, Plant & Equipment | -10.64% | 285.07% | -19.55% | -20.27% | -16.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.78% | 34.33% | -17.28% | -6.90% | -7.45% |
| Total Assets | -5.34% | 33.06% | 14.97% | 31.73% | 248.09% |
|
|
|||||
| Total Accounts Payable | -53.58% | -26.98% | -34.33% | -33.16% | 65.77% |
| Total Accrued Expenses | -38.79% | 27.57% | -8.58% | 13.45% | -2.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.31% | 152.55% | -35.07% | -25.70% | -2.74% |
| Total Finance Division Other Current Liabilities | -86.59% | 219.37% | -37.60% | 2.38% | 58.77% |
| Total Other Current Liabilities | -86.59% | 219.37% | -37.60% | 2.38% | 58.77% |
| Total Current Liabilities | -74.35% | 127.45% | -32.15% | -7.53% | 43.26% |
|
|
|||||
| Total Current Liabilities | -74.35% | 127.45% | -32.15% | -7.53% | 43.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.25% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -7.32% | 7.89% | -- |
| Total Liabilities | -69.93% | 144.29% | -31.93% | -7.42% | 41.81% |
|
|
|||||
| Common Stock & APIC | 5.15% | 11.10% | 7.22% | 9.27% | 20.86% |
| Retained Earnings | -7.62% | -4.62% | -3.77% | -2.66% | -2.89% |
| Treasury Stock & Other | -17.18% | -4.07% | 30.72% | -11.32% | -6.83% |
| Total Common Equity | -0.28% | 28.48% | 18.33% | 35.84% | 310.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -0.28% | 28.48% | 18.33% | 35.84% | 310.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -0.28% | 28.48% | 18.33% | 35.84% | 310.85% |
|
|
|||||